Table 2.
Corticosteroid Characterization
| Frequency of Use Days 0–1 n/N (%) | Frequency of Use on Study n/N (%) | Amount1 (mg/kg/day) | Duration2 (Days) | |
|---|---|---|---|---|
| Any Steroid | 160/352 (45%) | 229/352 (65%) | -- | -- |
| Hydrocortisone | 120/160 (75%) | 143/229 (63%) | 1.9 [0.9, 3.0] | 5 [3, 8] |
| Methylprednisolone | 47/160 (29%) | 65/229 (28%) | 1.9 [1.0, 2.9] | 6 [3, 8] |
| Dexamethasone | 5/160 (3%) | 77/229 (34%) | 0.5 [0.3, 1.0] | 2 [1, 3] |
| Prednisone or Prednisolone | 0/160 (0%) | 18/229 (8%) | 1.1 [0.9, 2.0] | 2 [1, 6] |
1
There were 25 of 1664 daily corticosteroid administration totals where the value entered was unable to be converted to mg/kg/day.
2
Corticosteroid administrations were recorded on study Days 0–28 inclusive. Duration is defined as the sum of calendar days the patient was administered steroids. Each steroid duration summary only includes patients receiving the medication.
*
Median [Q1, Q2] are reported for continuous summaries.